NYSE$CMP
Compass Minerals International Inc. · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
Compass Minerals' core businesses showed strong results, but overall performance was impacted by historical accounting matters.
Compass Minerals reported preliminary fiscal year 2024 third-quarter results, highlighting strong performance in the core Salt and Plant Nutrition businesses. Revenue was $202.9 million, with an operating income of $5.9 million. However, the company reported a net loss of $43.6 million, impacted by ongoing financial restatements.
- Preliminary adjusted EBITDA was $32.8 million, including a $0.9 million non-cash gain from the decrease of the Fortress contingent liability.
- The Salt segment demonstrated strong performance with adjusted EBITDA per ton of $28.05.
- The midpoint of Salt business adjusted EBITDA guidance increased $15 million for 2024.
- The average sales price for sulfate of potash increased for the second consecutive quarter to $691.27 per ton.
Headline financials
Revenue & EPS history
Compass Minerals · Revenue · Quarterly
$203M
Revenue by segment
Compass Minerals · $156M total across 1 segment · Q3 2022
- Salt Segment$156M—100.0%
Forward guidance
Compass Minerals provided preliminary updated guidance for 2024, with improved expectations for Salt segment adjusted EBITDA and revised guidance for the Plant Nutrition segment.
Tailwinds
- Salt segment revenue is expected to be between $900 million and $910 million.
- Salt segment adjusted EBITDA is projected to be between $215 million and $225 million.
- The company anticipates lower costs related to the curtailment of the Goderich mine.
- The company is working toward reducing salt inventory levels and accelerating conversion of excess inventory to cash.
- Approximately 70% of the company's North American highway deicing bidding process for the upcoming winter season has been completed.
Headwinds
- The company expects its average contract selling price for the coming season to be approximately 2% lower than prices in fiscal 2024.
- Market bid volumes are expected to be down approximately 7% to 10% compared to fiscal 2024.
- Plant Nutrition revenue is expected to be between $175 million and $185 million.
- Plant Nutrition adjusted EBITDA is projected to be between $21 million and $26 million.
- The revised Plant Nutrition guidance reflects lower sales volumes and increased costs, partially offset by higher realized pricing.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
-1.1%
Avg return
Earnings day
-0.5%
Avg return
5 days after
+0.5%
Avg return
30 days after
40%
27 / 67 earnings
Positive
+26.5%
Q2 2025
Best reaction
-20.5%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | +6.8% | +10.8% | +11.7% | |
| Q1 2026 | -14.8% | -13.0% | -7.8% | |
| Q4 2025 | -14.4% | -15.9% | +8.9% | |
| Q2 2025 | +26.5% | +38.7% | +39.8% | |
| Q1 2025 | -5.8% | -7.3% | -17.5% | |
| Q4 2024 | -2.1% | -18.4% | +2.9% | |
| Q3 2024 | +17.9% | +23.1% | +48.1% | |
| Q2 2024 | +2.0% | -6.1% | +3.0% | |
| Q1 2024 | -5.3% | +1.6% | -6.9% | |
| Q4 2023 | -8.4% | -1.7% | +1.2% | |
| Q3 2023 | -5.2% | -12.0% | -25.1% | |
| Q2 2023 | +0.3% | +8.2% | +14.5% | |
| Q1 2023 | -14.3% | -15.1% | -20.0% | |
| Q4 2022 | +9.6% | +13.4% | +1.6% | |
| Q3 2022 | +1.5% | +7.7% | +5.2% | |
| Q2 2022 | -20.5% | -28.6% | -26.6% | |
| Q1 2022 | -4.3% | -4.7% | +9.6% | |
| Q4 2021 | -4.3% | -4.7% | +9.6% | |
| Q2 2021 | -1.6% | -5.3% | -3.4% | |
| Q1 2021 | -0.3% | +0.5% | -2.3% | |
| Q4 2020 | -3.1% | +2.3% | +4.3% | |
| Q3 2020 | -7.0% | -0.1% | +5.8% | |
| Q2 2020 | +9.1% | +11.6% | +9.8% | |
| Q1 2020 | +1.1% | +2.7% | +12.1% | |
| Q4 2019 | +10.2% | +7.3% | -26.7% | |
| Q3 2019 | -7.4% | -4.2% | -6.8% | |
| Q2 2019 | -5.2% | -1.0% | -3.0% | |
| Q1 2019 | -4.1% | -2.5% | -9.9% | |
| Q4 2018 | +1.8% | +4.5% | -0.8% | |
| Q3 2018 | +8.6% | +8.6% | +5.8% | |
| Q2 2018 | -4.6% | -7.5% | -9.9% | |
| Q1 2018 | +3.1% | +3.2% | -2.8% | |
| Q4 2017 | -2.6% | -9.7% | -10.5% | |
| Q3 2017 | -1.0% | -0.8% | +4.2% | |
| Q2 2017 | -2.3% | -5.8% | +0.0% | |
| Q1 2017 | +1.4% | +6.2% | +1.2% | |
| Q4 2016 | -1.8% | -1.4% | -9.9% | |
| Q3 2016 | -1.5% | -0.3% | +10.1% | |
| Q2 2016 | -0.1% | -3.3% | +2.1% | |
| Q1 2016 | +2.4% | — | — | |
| Q4 2015 | -1.1% | — | — | |
| Q3 2015 | -3.2% | — | — | |
| Q2 2015 | +1.2% | — | — | |
| Q1 2015 | +3.6% | — | — | |
| Q4 2014 | +1.0% | — | — | |
| Q3 2014 | +0.6% | — | — | |
| Q2 2014 | -5.7% | — | — | |
| Q1 2014 | +5.2% | — | — | |
| Q4 2013 | -2.6% | — | — | |
| Q3 2013 | -2.2% | — | — | |
| Q2 2013 | -18.1% | — | — | |
| Q1 2013 | +6.4% | — | — | |
| Q4 2012 | +1.6% | — | — | |
| Q3 2012 | +2.4% | — | — | |
| Q2 2012 | -2.4% | — | — | |
| Q1 2012 | +1.7% | — | — | |
| Q4 2011 | +1.2% | — | — | |
| Q3 2011 | -5.5% | — | — | |
| Q2 2011 | -7.2% | — | — | |
| Q4 2010 | -7.2% | — | — | |
| Q1 2010 | +4.0% | — | — | |
| Q1 2011 | +2.3% | — | — | |
| Q2 2010 | -4.2% | — | — | |
| Q4 2008 | -4.2% | — | — | |
| Q3 2010 | -0.7% | — | — | |
| Q4 2009 | -0.7% | — | — | |
| Q3 2009 | -0.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro